The cost would be over a long term I would think and if revenue is generated, that cost would be then offset by the amount of revenue being generated. If Generex makes quite a bit of revenue through the acquisitions, hopefully we will be fine. If not, then ......
This is where Nasdaq uplifting really needs to come in.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links